Cargando…
Salt-inducible kinase 3 is a novel mitotic regulator and a target for enhancing antimitotic therapeutic-mediated cell death
Many mitotic kinases are both critical for maintaining genome stability and are important targets for anticancer therapies. We provide evidence that SIK3 (salt-inducible kinase 3), an AMP-activated protein kinase-related kinase, is important for mitosis to occur properly in mammalian cells. Downregu...
Autores principales: | Chen, H, Huang, S, Han, X, Zhang, J, Shan, C, Tsang, Y H, Ma, H T, Poon, R Y C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001308/ https://www.ncbi.nlm.nih.gov/pubmed/24743732 http://dx.doi.org/10.1038/cddis.2014.154 |
Ejemplares similares
-
FOXM1 repression increases mitotic death upon antimitotic chemotherapy through BMF upregulation
por: Vaz, Sara, et al.
Publicado: (2021) -
STARD9/Kif16a is a novel mitotic kinesin and antimitotic target
por: Torres, Jorge Z.
Publicado: (2012) -
HSP90 Inhibition Enhances Antimitotic Drug-Induced Mitotic Arrest and Cell Death in Preclinical Models of Non-Small Cell Lung Cancer
por: O'Connell, Brenda C., et al.
Publicado: (2014) -
PCTAIRE1 promotes mitotic progression and resistance against antimitotic and apoptotic signals
por: Gillani, Syed Qaaifah, et al.
Publicado: (2022) -
BCL-W is a regulator of microtubule inhibitor-induced mitotic cell death
por: Huang, Shan, et al.
Publicado: (2016)